Annie Schwartz

1.0k total citations
31 papers, 777 citations indexed

About

Annie Schwartz is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Annie Schwartz has authored 31 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Genetics and 8 papers in Oncology. Recurrent topics in Annie Schwartz's work include RNA and protein synthesis mechanisms (18 papers), DNA and Nucleic Acid Chemistry (14 papers) and Bacterial Genetics and Biotechnology (14 papers). Annie Schwartz is often cited by papers focused on RNA and protein synthesis mechanisms (18 papers), DNA and Nucleic Acid Chemistry (14 papers) and Bacterial Genetics and Biotechnology (14 papers). Annie Schwartz collaborates with scholars based in France, Germany and United States. Annie Schwartz's co-authors include Marc Boudvillain, Marc Leng, Nara Figueroa‐Bossi, A. Rachid Rahmouni, Lionello Bossi, Laurent Marrot, F D’Heygere, Jean‐Marc Malinge, Miroslav Šíp and Emmanuel Margeat and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Annie Schwartz

31 papers receiving 765 citations

Peers

Annie Schwartz
John E. Mott United States
Sudip S. Parikh United States
Li‐Ming Changchien United States
Rajika L. Perera United Kingdom
S Chang United States
Gregory J. S. Lohman United States
Christian Lizak Switzerland
John E. Mott United States
Annie Schwartz
Citations per year, relative to Annie Schwartz Annie Schwartz (= 1×) peers John E. Mott

Countries citing papers authored by Annie Schwartz

Since Specialization
Citations

This map shows the geographic impact of Annie Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Schwartz more than expected).

Fields of papers citing papers by Annie Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Schwartz. The network helps show where Annie Schwartz may publish in the future.

Co-authorship network of co-authors of Annie Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Schwartz. A scholar is included among the top collaborators of Annie Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Schwartz. Annie Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eveno, Éric, et al.. (2022). A scalable framework for the discovery of functional helicase substrates and helicase-driven regulatory switches. Proceedings of the National Academy of Sciences. 119(38). e2209608119–e2209608119. 3 indexed citations
2.
Schwartz, Annie, et al.. (2018). Evaluating the Effect of Small RNAs and Associated Chaperones on Rho-Dependent Termination of Transcription In Vitro. Methods in molecular biology. 1737. 99–118. 5 indexed citations
3.
D’Heygere, F, Annie Schwartz, F Coste, B. Castaing, & Marc Boudvillain. (2015). ATP-dependent motor activity of the transcription termination factor Rho fromMycobacterium tuberculosis. Nucleic Acids Research. 43(12). 6099–6111. 22 indexed citations
5.
Figueroa‐Bossi, Nara, et al.. (2014). RNA remodeling by bacterial global regulator CsrA promotes Rho-dependent transcription termination. Genes & Development. 28(11). 1239–1251. 84 indexed citations
6.
D’Heygere, F, Annie Schwartz, F Coste, B. Castaing, & Marc Boudvillain. (2014). Monitoring RNA Unwinding by the Transcription Termination Factor Rho from Mycobacterium tuberculosis. Methods in molecular biology. 1259. 293–311. 6 indexed citations
7.
Bossi, Lionello, et al.. (2012). A role for Rho-dependent polarity in gene regulation by a noncoding small RNA. Genes & Development. 26(16). 1864–1873. 96 indexed citations
8.
Schwartz, Annie, et al.. (2012). Analysis of Helicase–RNA Interactions Using Nucleotide Analog Interference Mapping. Methods in enzymology on CD-ROM/Methods in enzymology. 511. 149–169. 2 indexed citations
9.
Espéli, Olivier, Annie Schwartz, Bastien Cayrol, et al.. (2011). The Sm‐like RNA chaperone Hfq mediates transcription antitermination at Rho‐dependent terminators. The EMBO Journal. 30(14). 2805–2816. 83 indexed citations
10.
Boudvillain, Marc, et al.. (2009). Simple Enzymatic Assays for the In Vitro Motor Activity of Transcription Termination Factor Rho from Escherichia coli. Methods in molecular biology. 587. 137–154. 17 indexed citations
11.
Schwartz, Annie, et al.. (2009). A stepwise 2′-hydroxyl activation mechanism for the bacterial transcription termination factor Rho helicase. Nature Structural & Molecular Biology. 16(12). 1309–1316. 30 indexed citations
12.
Schwartz, Annie, Emmanuel Margeat, A. Rachid Rahmouni, & Marc Boudvillain. (2007). Transcription Termination Factor Rho Can Displace Streptavidin from Biotinylated RNA. Journal of Biological Chemistry. 282(43). 31469–31476. 29 indexed citations
14.
Schmidt, Kathrin, Marc Boudvillain, Annie Schwartz, et al.. (2002). Monofunctionally trans ‐Diammine Platinum( II )‐Modified Peptide Nucleic Acid Oligomers: A New Generation of Potential Antisense Drugs. Chemistry - A European Journal. 8(24). 5566–5570. 33 indexed citations
15.
Leng, Marc, Daniel Locker, Marie‐Josèphe Giraud‐Panis, et al.. (2000). Replacement of an NH3 by an Iminoether in Transplatin Makes an Antitumor Drug from an Inactive Compound. Molecular Pharmacology. 58(6). 1525–1535. 2 indexed citations
16.
Decoville, Martine, Annie Schwartz, Daniel Locker, & Marc Leng. (1993). Detection of minor adducts in cisplatin‐modified DNA by transcription footprinting. FEBS Letters. 323(1-2). 55–58. 11 indexed citations
17.
Šíp, Miroslav, Annie Schwartz, Françoise Vovelle, Marius Ptak, & Marc Leng. (1992). Distortions induced in DNA by cis-platinum interstrand adducts. Biochemistry. 31(9). 2508–2513. 50 indexed citations
18.
Schwartz, Annie, Laurent Marrot, & Marc Leng. (1989). The DNA bending by acetylaminofluorene residues and by apurinic sites. Journal of Molecular Biology. 207(2). 445–450. 24 indexed citations
19.
Schwartz, Annie, Laurent Marrot, & Marc Leng. (1989). Conformation of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry. 28(20). 7975–7979. 40 indexed citations
20.
Rahmouni, A. Rachid, Jean‐Marc Malinge, Annie Schwartz, & Marc Leng. (1985). Comparison Between poly(dG-dC)·poly(dG-dC) and DNA Modified by cis-diamminedichloroplatinum (II): Immunological and Spectroscopic Studies. Journal of Biomolecular Structure and Dynamics. 3(2). 363–375. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026